Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome.

MLA

Acharya, Ratna, et al. “Efficacy and Safety of Eculizumab in Enteroaggregative E. Coli Associated Hemolytic Uremic Syndrome.” Pediatric Reports, vol. 16, no. 1, Mar. 2024, pp. 26–34. EBSCOhost, https://doi.org/10.3390/pediatric16010003.

APA

Acharya, R., Clapp, W. L., & Upadhyay, K. (2024). Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome. Pediatric Reports, 16(1), 26–34. https://doi.org/10.3390/pediatric16010003

Chicago

Acharya, Ratna, William L. Clapp, and Kiran Upadhyay. 2024. “Efficacy and Safety of Eculizumab in Enteroaggregative E. Coli Associated Hemolytic Uremic Syndrome.” Pediatric Reports 16 (1): 26–34. doi:10.3390/pediatric16010003.